MDPI and ACS Style
Backhaus, D.; Jentzsch, M.; Bischof, L.; Brauer, D.; Wilhelm, C.; Schulz, J.; Franke, G.-N.; Pönisch, W.; Vucinic, V.; Platzbecker, U.;
et al. Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Cancers 2021, 13, 5679.
https://doi.org/10.3390/cancers13225679
AMA Style
Backhaus D, Jentzsch M, Bischof L, Brauer D, Wilhelm C, Schulz J, Franke G-N, Pönisch W, Vucinic V, Platzbecker U,
et al. Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Cancers. 2021; 13(22):5679.
https://doi.org/10.3390/cancers13225679
Chicago/Turabian Style
Backhaus, Donata, Madlen Jentzsch, Lara Bischof, Dominic Brauer, Christina Wilhelm, Julia Schulz, Georg-Nikolaus Franke, Wolfram Pönisch, Vladan Vucinic, Uwe Platzbecker,
and et al. 2021. "Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation" Cancers 13, no. 22: 5679.
https://doi.org/10.3390/cancers13225679